D.E. Shaw & Co
NMTR

D.E. Shaw & Co’s 9 Meters Biopharma NMTR Stock Holding History

D.E. Shaw & Co’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-32,040
Closed -$384K – 5943
2022
Q1 		$384K Buy
32,040
+19,233
+150% +$263K ﹤0.01% 4522
2021
Q4 		$251K Sell
12,807
-21,122
-62% -$472K ﹤0.01% 4773
2021
Q3 		$882K Sell
33,929
-645
-2% -$15.2K ﹤0.01% 3703
2021
Q2 		$761K Buy
+34,574
New +$849K ﹤0.01% 3760

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWM
Curi Wealth Management Raleigh, North Carolina $724M AUM 17.43% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

D.E. Shaw & Co's NMTR Position: Q2 2022 in Review

D.E. Shaw & Co sold out of 9 Meters Biopharma (NMTR) in Q2 2022, closing a stake of 32,040 shares — an estimated $384K sold.

D.E. Shaw & Co first reported a position in NMTR in Q2 2021 and held it in 4 quarters. The position peaked at $882K in Q3 2021. 88 funds tracked by Wall St. Rank hold NMTR as of Q2 2022.

  • D.E. Shaw & Co reported no remaining 9 Meters Biopharma position as of Q2 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 32,040 9 Meters Biopharma shares in Q2 2022, an estimated $384K.
  • D.E. Shaw & Co first reported a position in 9 Meters Biopharma in Q2 2021 and held it in 4 quarters.
  • D.E. Shaw & Co's 9 Meters Biopharma position peaked at $882K in Q3 2021.
  • 88 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q2 2022.

Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.